CCR2 and non-small cell lung carcinoma: CAR T-cells transduced with CCR2b, the dominant isoform of CCR2, showed improved tumor infiltration and tumor control in mouse models, including successfully crossing the blood-brain barrier to control brain metastases from NSCLC (183–185).